BACKGROUND: The quality of well-being scale (QWB) and the Medical Outcome Study 36-item short form (SF-36) are alternative methods for measuring general health outcomes. Few studies compare these approaches against one another and no studies have compared German language versions. METHOD: A German language version of the self-administered quality of well-being scale (QWB-SA) was developed using forward and back translation methods. The German QWB-SA and a German language version of the SF-36 were administered to clinical population groups with current diagnoses of prostate cancer, benign hyperplasia of the prostate, colon cancer, and rectal cancer. Data were obtained from four German clinics. In addition to the quality of life measures, data on cancer stage and disease state were obtained. RESULTS: The QWB-SA and SF-36 were highly correlated. The QWB-SA was systematically related to disease state. Those with no symptomatic evidence had the highest scores followed by those who were stable with no metastatic disease and those with metastatic progression. Similar patterns were found for most SF-36 scales although the SF-36 failed to discriminate between those with no evidence of disease and those with stable disease without metastasis. CONCLUSIONS: Both the QWB-SA and SF-36 perform as expected using German language translations. Although both measures differentiate patients with metastasis from those without symptoms, the QWB-SA better differentiated those with no evidence of disease from those with stable disease without metastasis.
BACKGROUND: The quality of well-being scale (QWB) and the Medical Outcome Study 36-item short form (SF-36) are alternative methods for measuring general health outcomes. Few studies compare these approaches against one another and no studies have compared German language versions. METHOD: A German language version of the self-administered quality of well-being scale (QWB-SA) was developed using forward and back translation methods. The German QWB-SA and a German language version of the SF-36 were administered to clinical population groups with current diagnoses of prostate cancer, benign hyperplasia of the prostate, colon cancer, and rectal cancer. Data were obtained from four German clinics. In addition to the quality of life measures, data on cancer stage and disease state were obtained. RESULTS: The QWB-SA and SF-36 were highly correlated. The QWB-SA was systematically related to disease state. Those with no symptomatic evidence had the highest scores followed by those who were stable with no metastatic disease and those with metastatic progression. Similar patterns were found for most SF-36 scales although the SF-36 failed to discriminate between those with no evidence of disease and those with stable disease without metastasis. CONCLUSIONS: Both the QWB-SA and SF-36 perform as expected using German language translations. Although both measures differentiate patients with metastasis from those without symptoms, the QWB-SA better differentiated those with no evidence of disease from those with stable disease without metastasis.
Authors: S D Keller; J E Ware; B Gandek; N K Aaronson; J Alonso; G Apolone; J B Bjorner; J Brazier; M Bullinger; S Fukuhara; S Kaasa; A Leplège; R W Sanson-Fisher; M Sullivan; S Wood-Dauphinee Journal: J Clin Epidemiol Date: 1998-11 Impact factor: 6.437
Authors: R M Kaplan; J P Anderson; T L Patterson; J A McCutchan; J D Weinrich; R K Heaton; J H Atkinson; L Thal; J Chandler; I Grant Journal: Psychosom Med Date: 1995 Mar-Apr Impact factor: 4.312
Authors: Erik J Groessl; Robert M Kaplan; W Jack Rejeski; Jeffrey A Katula; Abby C King; Georita Frierson; Nancy W Glynn; Fang-Chi Hsu; Michael Walkup; Marco Pahor Journal: Am J Prev Med Date: 2007-09 Impact factor: 5.043
Authors: Erik J Groessl; Robert M Kaplan; W Jack Rejeski; Jeffrey A Katula; Nancy W Glynn; Abby C King; Stephen D Anton; Michael Walkup; Ching-Ju Lu; Kieran Reid; Bonnie Spring; Marco Pahor Journal: Am J Prev Med Date: 2019-01 Impact factor: 5.043
Authors: Murray Krahn; Karen E Bremner; George Tomlinson; Paul Ritvo; Jane Irvine; Gary Naglie Journal: Qual Life Res Date: 2006-11-08 Impact factor: 4.147
Authors: Elise L Lev; Lucille Sanzero Eller; Glen Gejerman; Patricia Lane; Steven V Owen; Michele White; Njoki Nganga Journal: Health Qual Life Outcomes Date: 2004-06-15 Impact factor: 3.186